{"id":"topical-calcipotriol","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation"},{"rate":null,"effect":"Burning sensation"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Erythema"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Calcipotriol activates the vitamin D receptor (VDR) on keratinocytes and immune cells in the skin, promoting normal cell maturation and reducing the abnormal proliferation characteristic of psoriasis. This leads to normalization of the epidermal differentiation process and anti-inflammatory effects through modulation of immune cell function.","oneSentence":"Calcipotriol is a vitamin D3 analog that binds to vitamin D receptors on skin cells to regulate cell proliferation and differentiation, reducing excessive skin cell growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:39:20.231Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Psoriasis (topical treatment)"},{"name":"Atopic dermatitis (topical treatment)"}]},"trialDetails":[{"nctId":"NCT07453472","phase":"PHASE3","title":"Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia","status":"NOT_YET_RECRUITING","sponsor":"Dr. Shalini Gupta","startDate":"2026-04","conditions":"Oral Leukoplakia","enrollment":166},{"nctId":"NCT07453238","phase":"PHASE4","title":"Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata","status":"NOT_YET_RECRUITING","sponsor":"Hayat Abad Medical Complex, Peshawar","startDate":"2026-04-01","conditions":"Alopecia Areata","enrollment":60},{"nctId":"NCT07401992","phase":"PHASE4","title":"Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2026-01-15","conditions":"Psoriasis (PsO), Obesity & Overweight, Diabetes Mellitus - Type 2","enrollment":62},{"nctId":"NCT06737406","phase":"NA","title":"Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children With Palmoplantar Wart","status":"RECRUITING","sponsor":"Mazandaran University of Medical Sciences","startDate":"2025-05-30","conditions":"Common Warts","enrollment":60},{"nctId":"NCT06851507","phase":"PHASE3","title":"A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-10-06","conditions":"Multiple Actinic Keratoses","enrollment":30},{"nctId":"NCT05185258","phase":"PHASE4","title":"Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2022-02-16","conditions":"Psoriasis Vulgaris, Psoriasis, Skin Diseases","enrollment":12},{"nctId":"NCT05699603","phase":"PHASE2","title":"Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arizona","startDate":"2024-07-02","conditions":"Actinic Keratosis","enrollment":56},{"nctId":"NCT06880042","phase":"EARLY_PHASE1","title":"COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO","status":"ENROLLING_BY_INVITATION","sponsor":"Dr ayesha wahid","startDate":"2025-05-01","conditions":"Vitiligo - Macular Depigmentation, Tacrolimus","enrollment":60},{"nctId":"NCT03370406","phase":"PHASE1","title":"Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC","status":"RECRUITING","sponsor":"Melissa Pugliano-Mauro","startDate":"2018-08-03","conditions":"Carcinoma, Squamous Cell","enrollment":30},{"nctId":"NCT06499415","phase":"PHASE4","title":"Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2024-09-04","conditions":"Actinic Keratoses","enrollment":232},{"nctId":"NCT03596073","phase":"PHASE1","title":"Topical Calcipotriene Treatment for Breast Cancer Immunoprevention","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2018-11-07","conditions":"Breast Cancer","enrollment":43},{"nctId":"NCT04329221","phase":"PHASE2","title":"Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01-01","conditions":"Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer","enrollment":""},{"nctId":"NCT04642287","phase":"PHASE2","title":"Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2026-01","conditions":"Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses","enrollment":""},{"nctId":"NCT01120223","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-05","conditions":"Scalp Psoriasis","enrollment":78},{"nctId":"NCT01083758","phase":"PHASE2","title":"Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Scalp Psoriasis","enrollment":31},{"nctId":"NCT03806790","phase":"PHASE3","title":"Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2019-01-24","conditions":"Psoriasis Vulgaris","enrollment":182},{"nctId":"NCT01188928","phase":"PHASE3","title":"LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-09","conditions":"Psoriasis Vulgaris","enrollment":1152},{"nctId":"NCT02310646","phase":"PHASE3","title":"Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-01","conditions":"Psoriasis Vulgaris","enrollment":219},{"nctId":"NCT01105286","phase":"PHASE1","title":"A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01837576","phase":"PHASE1","title":"An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01052467","phase":"","title":"Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-01","conditions":"Scalp Psoriasis","enrollment":724},{"nctId":"NCT02416258","phase":"PHASE2","title":"A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-04","conditions":"Skin and Connective Tissue Diseases","enrollment":50},{"nctId":"NCT01105234","phase":"PHASE1","title":"An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-04","conditions":"Irritation","enrollment":24},{"nctId":"NCT01229098","phase":"PHASE2","title":"Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-10","conditions":"Psoriasis Vulgaris","enrollment":102},{"nctId":"NCT06685588","phase":"NA","title":"Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses","status":"NOT_YET_RECRUITING","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2025-01","conditions":"Actinic Keratosis of Face and Scalp, Actinic Keratoses","enrollment":50},{"nctId":"NCT06333600","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss","status":"RECRUITING","sponsor":"Sohag University","startDate":"2023-05-20","conditions":"Dermatology, Female Pattern Baldness","enrollment":45},{"nctId":"NCT06327620","phase":"NA","title":"Treatment Of Oral Lichen Planus","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2022-01-15","conditions":"Lichen Planus","enrollment":15},{"nctId":"NCT04220554","phase":"NA","title":"Improvement of Psoriasis Patients' Adherence to Topical Drugs","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2020-06-19","conditions":"Psoriasis Vulgaris","enrollment":103},{"nctId":"NCT05954104","phase":"NA","title":"Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma","status":"COMPLETED","sponsor":"Egymedicalpedia","startDate":"2023-07-01","conditions":"Alopecia Areata","enrollment":80},{"nctId":"NCT05416320","phase":"EARLY_PHASE1","title":"Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-08","conditions":"Central Centrifugal Cicatricial Alopecia","enrollment":""},{"nctId":"NCT06011083","phase":"NA","title":"Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-08-01","conditions":"Psoriasis Vulgaris, Fractional CO2 Laser","enrollment":40},{"nctId":"NCT03392311","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2019-07-23","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Effect","enrollment":8},{"nctId":"NCT04275024","phase":"NA","title":"Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients","status":"COMPLETED","sponsor":"Guangdong Provincial Hospital of Traditional Chinese Medicine","startDate":"2020-04-01","conditions":"Mesenchymal Stromal Cells, Psoriasis, Drug Effect","enrollment":8},{"nctId":"NCT04839731","phase":"EARLY_PHASE1","title":"Combination 5-FU / Calcipotriene Cream for SCCIS/SCC","status":"UNKNOWN","sponsor":"Carilion Clinic","startDate":"2021-04-14","conditions":"Squamous Cell Carcinoma","enrollment":30},{"nctId":"NCT05249972","phase":"PHASE3","title":"A Phase III Study in Subjects With Mild to Moderate Psoriasis.","status":"UNKNOWN","sponsor":"Lipidor AB","startDate":"2022-01-24","conditions":"Mild to Moderate Psoriasis","enrollment":294},{"nctId":"NCT05488990","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Lipidor AB","startDate":"2013-03-25","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT00437255","phase":"PHASE4","title":"Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-08","conditions":"Plaque Psoriasis","enrollment":122},{"nctId":"NCT05174598","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis","status":"COMPLETED","sponsor":"Cadila Pharnmaceuticals","startDate":"2018-10-03","conditions":"Mild to Moderate Plaque Psoriasis","enrollment":278},{"nctId":"NCT04994951","phase":"PHASE2","title":"Pilot Study of Traditional Chinese Medicine (Qing-Re-Liang-Xue Decoction) as Complementary Medicine for Psoriasis Vulgaris of Blood-heat Syndrome.","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Zhejiang Chinese Medical University","startDate":"2021-09","conditions":"Psoriasis Vulgaris","enrollment":200},{"nctId":"NCT04380597","phase":"","title":"Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life","status":"COMPLETED","sponsor":"Angeles Florez","startDate":"2019-03-26","conditions":"Nail Psoriasis","enrollment":10},{"nctId":"NCT02935582","phase":"","title":"PSOREAL - Managing PSOriasis in the REAL World","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2017-01","conditions":"Psoriasis Vulgaris","enrollment":1214},{"nctId":"NCT01268527","phase":"PHASE2","title":"A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2010-03-15","conditions":"Psoriasis Vulgaris","enrollment":30},{"nctId":"NCT03506477","phase":"PHASE4","title":"Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2018-05-21","conditions":"Plaque Psoriasis, Psoriasis","enrollment":25},{"nctId":"NCT03996252","phase":"EARLY_PHASE1","title":"Combination Topical Therapy for Treatment of Scalp Actinic Keratoses","status":"TERMINATED","sponsor":"Tulane University","startDate":"2019-07-01","conditions":"Actinic Keratoses","enrollment":15},{"nctId":"NCT04571151","phase":"PHASE4","title":"Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis","status":"UNKNOWN","sponsor":"Skin Sciences, PLLC","startDate":"2021-01","conditions":"Plaque Psoriasis","enrollment":30},{"nctId":"NCT04221906","phase":"PHASE1","title":"Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Boston Pharmaceuticals","startDate":"2020-01-06","conditions":"Chronic Plaque Psoriasis","enrollment":15},{"nctId":"NCT03731091","phase":"PHASE3","title":"To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2018-10-31","conditions":"Psoriasis Vulgaris","enrollment":494},{"nctId":"NCT02878382","phase":"NA","title":"Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2016-10","conditions":"Actinic Keratosis","enrollment":20},{"nctId":"NCT03469336","phase":"PHASE1","title":"Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-04-24","conditions":"Psoriasis","enrollment":18},{"nctId":"NCT04372277","phase":"PHASE4","title":"Taltz in Combination With Enstilar for Psoriasis","status":"RECRUITING","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2020-04-28","conditions":"Psoriasis","enrollment":25},{"nctId":"NCT02881346","phase":"","title":"Efficacy and Tolerability of Enstilar® in Daily Practice","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-09","conditions":"Plaque Psoriasis","enrollment":410},{"nctId":"NCT02636101","phase":"","title":"Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-01","conditions":"Psoriasis Vulgaris","enrollment":603},{"nctId":"NCT04071106","phase":"PHASE2, PHASE3","title":"Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2019-09-01","conditions":"Psoriasis","enrollment":50},{"nctId":"NCT03093805","phase":"NA","title":"Topical Vitamin D in Acute Graft Versus Host Disease of the Skin","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2017-03-15","conditions":"Graft Vs Host Disease","enrollment":10},{"nctId":"NCT02858713","phase":"PHASE4","title":"Adherence in Topical Treatment of Psoriasis","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2017-01-09","conditions":"Adherence","enrollment":134},{"nctId":"NCT03584360","phase":"PHASE2","title":"Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2018-09-24","conditions":"Psoriasis Vulgaris","enrollment":30},{"nctId":"NCT03847441","phase":"NA","title":"Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2017-10-01","conditions":"Alopecia Areata","enrollment":60},{"nctId":"NCT03880357","phase":"PHASE1","title":"To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2018-10-22","conditions":"Scalp Psoriasis","enrollment":485},{"nctId":"NCT03866447","phase":"PHASE4","title":"Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-10-01","conditions":"Acne Vulgaris","enrollment":80},{"nctId":"NCT03848806","phase":"PHASE2","title":"Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"Haus Bioceuticals","startDate":"2016-02-29","conditions":"Psoriasis","enrollment":174},{"nctId":"NCT03004339","phase":"PHASE1","title":"Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"DFB Soria, LLC","startDate":"2016-08","conditions":"Plaque Psoriasis","enrollment":13},{"nctId":"NCT03827876","phase":"PHASE4","title":"Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis","status":"RECRUITING","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2019-01-16","conditions":"Psoriasis","enrollment":30},{"nctId":"NCT03331523","phase":"PHASE3","title":"To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2017-10-20","conditions":"Scalp Psoriasis","enrollment":643},{"nctId":"NCT02411643","phase":"EARLY_PHASE1","title":"Molecular Effects of Topical Calcipotriene on Morphea","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2015-03","conditions":"Morphea, Localized Scleroderma","enrollment":2},{"nctId":"NCT01707043","phase":"PHASE4","title":"Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2012-10","conditions":"Plaque Psoriasis","enrollment":20},{"nctId":"NCT02680717","phase":"PHASE1","title":"Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2016-03","conditions":"Scleroderma","enrollment":""},{"nctId":"NCT01563068","phase":"PHASE1","title":"Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis","status":"COMPLETED","sponsor":"Mayne Pharma International Pty Ltd","startDate":"2012-04","conditions":"Psoriasis","enrollment":18},{"nctId":"NCT03122353","phase":"PHASE1","title":"BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis","status":"COMPLETED","sponsor":"Tolmar Inc.","startDate":"2017-04-11","conditions":"Scalp Psoriasis","enrollment":699},{"nctId":"NCT01982552","phase":"","title":"An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-07","conditions":"Psoriasis Vulgaris","enrollment":147},{"nctId":"NCT03079973","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s","status":"WITHDRAWN","sponsor":"Polichem S.A.","startDate":"2017-05-15","conditions":"Nail Psoriasis","enrollment":""},{"nctId":"NCT03080545","phase":"PHASE4","title":"Enstilar in Combination With Biologic Agents","status":"COMPLETED","sponsor":"Psoriasis Treatment Center of Central New Jersey","startDate":"2017-05-01","conditions":"Psoriasis","enrollment":25},{"nctId":"NCT00358384","phase":"PHASE1","title":"Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09-26","conditions":"Psoriasis","enrollment":10},{"nctId":"NCT02856542","phase":"","title":"Real-life Evaluation of the Daivobet® Gel Applicator","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-05-23","conditions":"Plaque Psoriasis","enrollment":1560},{"nctId":"NCT02432027","phase":"PHASE1, PHASE2","title":"Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Prism Pharma Co., Ltd.","startDate":"2015-06","conditions":"Psoriasis","enrollment":14},{"nctId":"NCT01313221","phase":"PHASE3","title":"Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-04","conditions":"Psoriasis","enrollment":310},{"nctId":"NCT03069144","phase":"PHASE1, PHASE2","title":"Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis","status":"COMPLETED","sponsor":"Haus Bioceuticals","startDate":"2012-01-06","conditions":"Psoriasis, Psoriasis Vulgaris","enrollment":28},{"nctId":"NCT02999776","phase":"PHASE1","title":"Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis","status":"UNKNOWN","sponsor":"Pantec Biosolutions AG","startDate":"2016-11","conditions":"Psoriatic Plaque","enrollment":30},{"nctId":"NCT02976727","phase":"PHASE1","title":"Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2014-05","conditions":"Actinic Dermatosis","enrollment":48},{"nctId":"NCT02955576","phase":"NA","title":"Microneedle Patch for Psoriatic Plaques","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2016-09","conditions":"Psoriasis, Administration, Topical","enrollment":20},{"nctId":"NCT02193815","phase":"PHASE1","title":"A 12 Day Study To Evaluate A Topical Drug To Treat Plaque Psoriasis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2014-09","conditions":"Psoriasis Vulgaris","enrollment":15},{"nctId":"NCT02644954","phase":"PHASE3","title":"Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-01","conditions":"Psoriasis","enrollment":40},{"nctId":"NCT01989429","phase":"PHASE3","title":"Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients","status":"COMPLETED","sponsor":"Maruho Europe Limited","startDate":"2013-10","conditions":"Plaque Psoriasis","enrollment":788},{"nctId":"NCT02489643","phase":"NA","title":"Individualized Medical Training and Calcipotriol and Betamethasone Dipropionate Gel in Plaque Psoriasis","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2014-05","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT01646567","phase":"PHASE1","title":"SHP-141C in Plaque Type Psoriasis","status":"COMPLETED","sponsor":"TetraLogic Pharmaceuticals","startDate":"2012-09","conditions":"Plaque Type Psoriasis","enrollment":14},{"nctId":"NCT01743118","phase":"PHASE1","title":"Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Circassia Limited","startDate":"2013-03","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01763424","phase":"PHASE2, PHASE3","title":"Nicotinamide in the Treatment of Psoriasis","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2011-07","conditions":"Psoriasis","enrollment":66},{"nctId":"NCT00608777","phase":"PHASE4","title":"Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)","status":"TERMINATED","sponsor":"Derm Research, PLLC","startDate":"2008-01","conditions":"Plaque Psoriasis","enrollment":6},{"nctId":"NCT00940862","phase":"PHASE4","title":"Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Innovaderm Research Inc.","startDate":"2009-07","conditions":"Psoriasis, Vascular Inflammation, Coronary Atherosclerosis","enrollment":30},{"nctId":"NCT01413477","phase":"NA","title":"Nickel Desensitization Using Topical Therapy","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2011-08","conditions":"Allergic Contact Dermatitis","enrollment":24},{"nctId":"NCT00574249","phase":"PHASE3","title":"Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment","status":"COMPLETED","sponsor":"Abbott","startDate":"2007-11","conditions":"Chronic Plaque Psoriasis","enrollment":730},{"nctId":"NCT00987870","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of BFH772 in Psoriasis Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-09","conditions":"Psoriasis, Arthritis","enrollment":15},{"nctId":"NCT00871052","phase":"NA","title":"Calcipotriol and Polymorphic Light Eruption","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2009-03","conditions":"Polymorphic Light Eruption","enrollment":13},{"nctId":"NCT00796211","phase":"PHASE2","title":"A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis","status":"COMPLETED","sponsor":"Zalicus","startDate":"2008-11","conditions":"Plaque Psoriasis","enrollment":20},{"nctId":"NCT00578370","phase":"PHASE1, PHASE2","title":"Efficacy and Tolerability Study of Topical Ciclosporin in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"ISDIN","startDate":"2007-11","conditions":"Psoriasis","enrollment":25},{"nctId":"NCT00234728","phase":"NA","title":"Study of a New Dressing for Use With Topical Medications","status":"COMPLETED","sponsor":"Teikoku Pharma USA, Inc.","startDate":"2005-09","conditions":"Psoriasis","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":252,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Topical calcipotriol","genericName":"Topical calcipotriol","companyName":"Post Graduate Institute of Medical Education and Research, Chandigarh","companyId":"post-graduate-institute-of-medical-education-and-research-chandigarh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Calcipotriol is a vitamin D3 analog that binds to vitamin D receptors on skin cells to regulate cell proliferation and differentiation, reducing excessive skin cell growth. Used for Psoriasis (topical treatment), Atopic dermatitis (topical treatment).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}